107 related articles for article (PubMed ID: 1865485)
1. Preclinical toxicity study of a male injectable antifertility agent (styrene maleic anhydride) in rhesus monkeys, Macaca mulatta.
Sethi N; Srivastava RK; Nath D; Singh RK
J Med Primatol; 1991; 20(2):89-93. PubMed ID: 1865485
[TBL] [Abstract][Full Text] [Related]
2. Long-term toxicity studies of styrene maleic anhydride in rats.
Sethi N; Srivastava RK; Singh RK; Nath D
Biomed Environ Sci; 1990 Dec; 3(4):452-7. PubMed ID: 2096850
[TBL] [Abstract][Full Text] [Related]
3. Chronic toxicity of styrene maleic anhydride, a male contraceptive, in rhesus monkeys (Macaca mulatta).
Sethi N; Srivastava RK; Singh RK; Bhatia GS; Sinha N
Contraception; 1990 Sep; 42(3):337-47. PubMed ID: 2289393
[TBL] [Abstract][Full Text] [Related]
4. Contraception in male monkeys by intra-vas deferens injection of a pH lowering polymer.
Guha SK; Ansari S; Anand S; Farooq A; Misro MM; Sharma DN
Contraception; 1985 Jul; 32(1):109-18. PubMed ID: 4053602
[TBL] [Abstract][Full Text] [Related]
5. Teratological evaluation of an injectable male antifertility agent, styrene maleic anhydride, in rats.
Sethi N; Srivastava RK; Nath D; Singh RK
Int J Fertil; 1992; 37(3):183-7. PubMed ID: 1355766
[TBL] [Abstract][Full Text] [Related]
6. Reversibility with sodium bicarbonate of styrene maleic anhydride, an intravasal injectable contraceptive, in male rats.
Koul V; Srivastav A; Guha SK
Contraception; 1998 Oct; 58(4):227-31. PubMed ID: 9866004
[TBL] [Abstract][Full Text] [Related]
7. Intra-vas deferens injection of styrene maleic anhydride gel for male contraception: is it safe?
Singh AK
J Fam Plann Reprod Health Care; 2002 Oct; 28(4):208-9. PubMed ID: 12419065
[No Abstract] [Full Text] [Related]
8. Safety evaluation of a male injectable antifertility agent, styrene maleic anhydride, in rats.
Sethi N; Srivastava RK; Singh RK
Contraception; 1989 Feb; 39(2):217-26. PubMed ID: 2706990
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive reversal of intraluminal vas deferens polymer injection-induced azoospermia--technology.
Guha SK
Asian J Androl; 1999 Sep; 1(3):131-4. PubMed ID: 11250780
[TBL] [Abstract][Full Text] [Related]
10. RISUG (reversible inhibition of sperm under guidance)--an antimicrobial as male vas deferens implant for HIV free semen.
Guha SK
Med Hypotheses; 2005; 65(1):61-4. PubMed ID: 15893119
[TBL] [Abstract][Full Text] [Related]
11. Phase II clinical trial of a vas deferens injectable contraceptive for the male.
Guha SK; Singh G; Ansari S; Kumar S; Srivastava A; Koul V; Das HC; Malhotra RL; Das SK
Contraception; 1997 Oct; 56(4):245-50. PubMed ID: 9408706
[TBL] [Abstract][Full Text] [Related]
12. Histological changes in the vas deferens of rats after injection of a new male antifertility agent "SMA" and its reversibility.
Sethi N; Srivastava RK; Singh RK
Contraception; 1990 Mar; 41(3):333-9. PubMed ID: 2323221
[TBL] [Abstract][Full Text] [Related]
13. Histology of the rat vas deferens after injection of a non-occlusive chemical contraceptive.
Verma K; Misro MM; Singh H; Mahajan S; Ray AR; Guha SK
J Reprod Fertil; 1981 Nov; 63(2):539-42. PubMed ID: 7299756
[TBL] [Abstract][Full Text] [Related]
14. Male mediated teratogenic potential evaluation of new antifertility compound SMA in rabbit (Oryctolagus cuniculus).
Sethi N; Srivastava RK; Singh RK
Contraception; 1990 Aug; 42(2):215-23. PubMed ID: 2085972
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation for noninvasive reversal following long-term vas occlusion with styrene maleic anhydride in langur monkeys.
Lohiya NK; Manivannan B; Mishra PK; Sriram S; Bhande SS; Panneerdoss S
Contraception; 2005 Mar; 71(3):214-26. PubMed ID: 15722073
[TBL] [Abstract][Full Text] [Related]
16. Phase I clinical trial of an injectable contraceptive for the male.
Guha SK; Singh G; Anand S; Ansari S; Kumar S; Koul V
Contraception; 1993 Oct; 48(4):367-75. PubMed ID: 8222664
[TBL] [Abstract][Full Text] [Related]
17. Sperm characteristics and teratology in rats following vas deferens occlusion with RISUG and its reversal.
Lohiya NK; Suthar R; Khandelwal A; Goyal S; Ansari AS; Manivannan B
Int J Androl; 2010 Feb; 33(1):e198-206. PubMed ID: 19811546
[TBL] [Abstract][Full Text] [Related]
18. Intravasal contraception with styrene maleic anhydride and its noninvasive reversal in langur monkeys (Presbytis entellus entellus).
Lohiya NK; Manivannan B; Mishra PK; Pathak N; Balasubramanian SP
Contraception; 1998 Aug; 58(2):119-28. PubMed ID: 9773267
[TBL] [Abstract][Full Text] [Related]
19. Time-controlled injectable occlusion of the vas deferens.
Guha SK; Anand S; Ansari S; Farooq A; Sharma DN
Contraception; 1990 Mar; 41(3):323-31. PubMed ID: 2323220
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructural changes in the vas deferens of langur monkeys Presbytis entellus entellus after vas occlusion with styrene maleic anhydride and after its reversal.
Manivannan B; Mishra PK; Lohiya NK
Contraception; 1999 Feb; 59(2):137-44. PubMed ID: 10361629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
